Searchable abstracts of presentations at key conferences in endocrinology

ea0056p876 | Pituitary - Clinical | ECE2018

The change in metabolic parametres of prolactinoma patients after therapy intervention

Dagdelen Duran Iffet , Ersoz Gulcelik Nese , Berker Dilek

Introduction: Prolactinoma is the prolactin secreting tumor of the pituitary gland which exerts mainly hypogonadal complaints and sometimes symptoms due to mass effect. Meanwhile it was mentioned to cause metabolic abnormalities such as increased fasting plasma glucose (FPG), Low Density Lipoprotein(LDL) cholesterol and triglycerides(TG). We studied whether some of these metabolic parametres of prolactinoma patients could be changed after the therapy.Met...